Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gentherm (THRM) Cash & Equivalents (2016 - 2025)

Gentherm (THRM) has 16 years of Cash & Equivalents data on record, last reported at $160.8 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 19.9% year-over-year to $160.8 million; the TTM value through Dec 2025 reached $160.8 million, up 19.9%, while the annual FY2025 figure was $160.8 million, 19.9% up from the prior year.
  • Cash & Equivalents reached $160.8 million in Q4 2025 per THRM's latest filing, up from $154.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $195.1 million in Q3 2021 and bottomed at $123.5 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $157.5 million, with a median of $155.8 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: fell 28.97% in 2021, then soared 30.4% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $190.6 million in 2021, then dropped by 19.26% to $153.9 million in 2022, then dropped by 2.74% to $149.7 million in 2023, then decreased by 10.38% to $134.1 million in 2024, then increased by 19.9% to $160.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $160.8 million in Q4 2025, $154.2 million in Q3 2025, and $128.3 million in Q2 2025.